Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
about
Extreme Procalcitonin Elevation without Proven Bacterial Infection Related to Amphetamine AbuseSerum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis and serum C-reactive protein, procalcitonin and lactate dehydrogenase for the diagnosis of pancreatic necrosisBiomarkers in chronic obstructive pulmonary disease: confusing or useful?IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in InfectionsCalcium-Sensing Receptor Gene: Regulation of ExpressionMicrofluidic system for monitoring temporal variations of hemorheological properties and platelet adhesion in LPS-injected rats.Biomarker discovery and development in pediatric critical care medicine.Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty.Differential effects of Calca-derived peptides in male mice with diet-induced obesityProcalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study.Procalcitonin beyond the acute phase: novel biomediator properties?Role of cytokines as a double-edged sword in sepsisAssessment of procalcitonin to predict outcome in hypothermia-treated patients after cardiac arrest.Diagnostic value of serum procalcitonin level in differentiating bacterial from nonbacterial meningitis in children.Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate.Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults.Procalcitonin and mortality in status epilepticus: an observational cohort study.Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria.Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritisBacterial complications of respiratory tract viral illness: a comprehensive evaluation.Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection: An Observational Study of 35,343 Consecutive Patients (A STROBE-Compliant Article).Clinical significance of serum procalcitonin in patients with ulcerative colitisCase of severe alcoholic hepatitis treated with granulocytapheresis.Determining prognosis in acute exacerbation of COPD.Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgeryThe first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro.Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisisEstablished and novel biomarkers of sepsis.Postmortem chemistry update part II.Immune regulation of procalcitonin: a biomarker and mediator of infection.Procalcitonin: present and future.Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.Intravenous immunoglobulin preparation prevents the production of pro-inflammatory cytokines by modulating NFκB and MAPKs pathways in the human monocytic THP-1 cells stimulated with procalcitonin.Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment
P2860
Q21284729-4966B5DC-C4DE-40C4-A892-514F4ADC02D4Q24187345-E1E9ABBA-C87A-49B2-A91E-B40D07AF012FQ27690280-A3A48CAE-791C-4DE2-AE8A-68CA6A322D22Q28072571-12573EDD-2A8C-4225-8757-80CB05B66602Q28079054-52D2D6A5-FFD1-44E2-A86D-B5885BEC8A2AQ29994808-9B7CC3D7-16DC-4B5C-852D-AFCD3E894120Q30428168-02D150CA-A281-42A7-B440-347C99B13422Q33557838-0F4F2533-E1EF-40C9-8264-6A960BD2A587Q33634769-40E75039-2A0F-406D-BB21-9B278963DEC5Q33860361-FF0E1CF6-0136-4639-818A-45874A374697Q34027944-06E2804E-7675-4E1B-8336-90BF802FFA27Q34262422-E5A2B64A-06EF-4684-8F25-BC7412D971D1Q34383078-21E8F11F-FC66-4E76-9300-43FB6AC2C039Q34929410-2AA43909-6F70-4FAA-9A09-155EBE11699EQ34975737-75E30518-2A52-4536-A9E5-259687B29762Q35230688-CBB33634-D218-45C1-98BB-023C9AA472DDQ35494130-B9E793FF-A13D-4FF0-B27E-352D21ED3869Q35642799-4D4A4002-1B07-4926-8CE0-6CB9AA8F2D12Q35797353-F4169F3F-2BFF-457A-B108-E7EAD915F4C5Q35857871-F8407493-298F-4B70-9B6D-A3A7D535AAB9Q36049031-6E54E0C1-8767-4A11-9E3E-3090639614DFQ36139745-0B36BB1E-FA09-4991-B41D-9BBE5D249AD5Q36602002-EF673A37-4372-4DEA-9412-7E9118D47309Q36715337-4F73DBED-53F4-4D6F-BF2B-49639B4F9B4EQ36974947-40ACBC6C-8050-4903-9E66-79B791D55AD0Q37026111-32CCD5F8-A66D-4B02-9A6A-A58B7758B1F0Q37378946-38B1C64F-1817-40AA-B0AE-D06B4EA759C9Q37418907-B1A3975A-3A80-488B-B4DA-94E759C5F794Q37626461-80376DDC-60B7-4258-9F25-DBB3699BF759Q37640547-106DAC27-6953-458D-8876-662C5A90F316Q37661557-770232B6-2E66-4E40-9B0F-FC8977FBD600Q37663041-7777BFE1-3618-40E6-8C2F-BDECFF9FA0C3Q37862741-8B1E6D36-AFA4-4DDC-8773-6035599D97F9Q37943748-1F0D9581-C4B2-4A00-A7BB-3DDCF112E26FQ37987042-8870B83C-4220-46D6-871D-55F92DE5C6EFQ38544528-78EA59E5-262C-4B4C-9A46-FB84015BDF62Q38550893-9F99D66C-8DEB-4362-BAA8-30A2208E68D3Q38826374-3099D0EE-F70C-4C25-B3E0-7F2453E66BC3Q38990805-42403D29-3A15-4F7B-9431-C7C3EA7BBA06Q40339604-322C6431-8799-46FC-AA31-0FCB0BF05501
P2860
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@en
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@nl
type
label
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@en
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@nl
prefLabel
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@en
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@nl
P2093
P2860
P921
P1476
Procalcitonin in sepsis and sy ...... rker and a therapeutic target.
@en
P2093
Eric S Nylen
Kenneth L Becker
Richard Snider
P2860
P304
P356
10.1111/J.1476-5381.2009.00433.X
P407
P577
2009-11-27T00:00:00Z